Hong Kong SAR, China - Medicaments Containing Insulin But Not Antibiotics - Market Analysis, Forecast, Size, Trends And Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingMedicaments Containing Insulin Price in Hong Kong SAR - 2022
Contents:
- Medicaments Containing Insulin Price in Hong Kong SAR (CIF) - 2022
- Medicaments Containing Insulin Price in Hong Kong SAR (FOB) - 2022
- Medicaments Containing Insulin Imports in Hong Kong SAR
- Medicaments Containing Insulin Exports in Hong Kong SAR
Medicaments Containing Insulin Price in Hong Kong SAR (CIF) - 2022
The average medicaments containing insulin import price stood at $360,333 per ton in 2022, increasing by 20% against the previous year. Over the period under review, the import price continues to indicate resilient growth. The most prominent rate of growth was recorded in 2019 an increase of 149%. Over the period under review, average import prices hit record highs in 2022 and is expected to retain growth in the immediate term.
As there is only one major supplying country, the average price level is determined by prices for the United States.
From 2012 to 2022, the rate of growth in terms of prices for the United States amounted to +8.5% per year.
Medicaments Containing Insulin Price in Hong Kong SAR (FOB) - 2022
The average medicaments containing insulin export price stood at $295 per ton in 2022, with a decrease of -99.7% against the previous year. Over the period under review, the export price recorded a precipitous descent. The pace of growth was the most pronounced in 2019 an increase of 190%. The export price peaked at $93,500 per ton in 2021, and then fell markedly in the following year.
As there is only one major export destination, the average price level is determined by prices for Denmark.
From 2012 to 2022, the rate of growth in terms of prices for Denmark amounted to -99.7% per year.
Medicaments Containing Insulin Imports in Hong Kong SAR
In 2022, medicaments containing insulin imports into Hong Kong SAR fell markedly to 6 kg, shrinking by -25% on 2021 figures. Over the period under review, imports showed a deep contraction.
In value terms, medicaments containing insulin imports contracted to $2.2K in 2022. Overall, imports continue to indicate a perceptible descent. The pace of growth was the most pronounced in 2021 with an increase of 26% against the previous year. As a result, imports attained the peak of $2.4K, and then contracted in the following year.
| Import of Medicaments Containing Insulin in Hong Kong SAR (Thousand USD) | |||||
|---|---|---|---|---|---|
| COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
| United States | 2.4 | 1.3 | 2.4 | 2.2 | -2.9% |
| Australia | N/A | 0.6 | N/A | N/A | 0% |
| Others | N/A | N/A | N/A | N/A | 0% |
| Total | 2.4 | 1.9 | 2.4 | 2.2 | -2.9% |
Top Suppliers of Medicaments Containing Insulin to Hong Kong SAR in 2022:
- United States (6.0 kg)
Medicaments Containing Insulin Exports in Hong Kong SAR
In 2022, exports of medicaments containing insulin but not antibiotics from Hong Kong SAR skyrocketed to 718 kg, jumping by 35,800% compared with the year before. Over the period under review, exports, however, faced a sharp reduction.
In value terms, medicaments containing insulin exports rose markedly to $212 in 2022. Overall, exports, however, saw a significant decrease.
| Export of Medicaments Containing Insulin in Hong Kong SAR (Thousand USD) | |||||
|---|---|---|---|---|---|
| COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
| Denmark | N/A | N/A | 0.1 | 0.1 | 0.0% |
| Angola | 76.5 | N/A | N/A | N/A | 0% |
| Others | N/A | N/A | 0.1 | 0.1 | 0.0% |
| Total | 76.5 | N/A | 0.2 | 0.2 | -86.2% |
Top Export Markets for Medicaments Containing Insulin from Hong Kong SAR in 2022:
- Denmark (359.0 kg)
This report provides an in-depth analysis of the medicaments containing insulin market in Hong Kong SAR, China. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale
Country coverage:
- Hong Kong SAR
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in Hong Kong SAR, China
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
345
This report provides an in-depth analysis of the medicaments containing insulin market in Hong Kong SAR, China.
259
This report provides an in-depth analysis of the medicaments containing hormones market in Hong Kong SAR, China.
303
This report provides an in-depth analysis of the medicaments containing penicillin market in Hong Kong SAR, China.
171
This report provides an in-depth analysis of the market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses in Hong Kong SAR, China.
217
This report provides an in-depth analysis of the market for medicaments of alkaloids or derivatives thereof in Hong Kong SAR, China.
220
This report provides an in-depth analysis of the market for medicaments of other antibiotics in Hong Kong SAR, China.
476
This report provides an in-depth analysis of the global medicaments containing insulin market.
481
This report provides an in-depth analysis of the global medicaments containing hormones market.
570
This report provides an in-depth analysis of the global medicaments containing penicillin market.
305
This report provides an in-depth analysis of the global market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses.
79
Explore the top 10 import markets for non-antibiotic, non-hormone, non-alkaloid medicaments based on the latest data. Discover the key countries driving the demand for therapeutic and prophylactic medicaments.
79
Explore the top 10 import markets for non-antibiotic, non-hormone, non-alkaloid medicaments based on the latest data. Discover the key countries driving the demand for therapeutic and prophylactic medicaments.
